Global Companion Diagnostics market | Inkwood Research
                     GLOBAL COMPANION DIAGNOSTICS 
MARKET
FORECAST 2018-2026
TREY 1
research
Insert or Drag & Drop your photo MARKET 
GLOBAL COMPANION 
DIAGNOSTICS MARKET OVERVIEW
• The global companion diagnostics market is 
FORECAST 2018-2026 segmented on the basis of technology, products and services, indications and end-
users.
• The technology segment includes polymerase 
chain reaction, in situ hybridization, 
immunohistochemistry, next-generation 
sequencing and other technologies.
• The product and service segment includes 
assay kits and reagents and software and 
service.
• The indication segment is further classified into 
oncology, neurology, infectious diseases and 
other indications.
• The market caters to end-users like 
pharmaceutical and biopharmaceutical 
companies, reference laboratories and other 
end users. 
TREY 
2
research
• KThe EglobYal c ompanion diagnostics market is 
driven by factors such as the widespread of 
cancer disease across the globe, high 
FdemIaNnd foDr tarIgeNt theGrapiSes and strategic initiatives for companion diagnostics test 
development.
• By the end of the forecast period of 2018-
2026, the market is expected to rise with a 
18.45% CAGR.
INTRODUCTI
ON
Global Companion Diagnostics 
market by Products and Services, by 
Indication, by End user, by 
Technology & by geography.
TREY 
3
research
TREY 
 4
research
Infograp
hic
REQUEST FREE SAMPLE
To know more about the latest trends  and innovation 
in the Global Companion Diagnostics market
Request free 
sample
TREY  5
research
NORTH AMERICA COMPANION DIAGNOSTICS 
MARKET
• The North America companion 
diagnostics market is projected to rise 
with a CAGR of 18.62% over the 
forecast period of 2018-2026.
• Initiatives to promote precision 
medicine research along with the 
strategic alliances between key market 
players for companion diagnostics test 
development are factors that are 
responsible for propelling the market 
growth. 
Request free 
sample TREY  6
research
EUROPE COMPANION DIAGNOSTICS MARKET
• High demand for target therapy and 
growing efforts to develop advanced 
companion diagnostics tests are factors 
that are driving growth in the Europe 
companion diagnostics market.
• Over the forecast period of 2018-2026, the 
Europe companion diagnostic market is 
expected to register a CAGR of 18.17%.
Request free 
sample TREY  7
research
ASIA PACIFIC COMPANION DIAGNOSTICS MARKET
• The Asia-Pacific companion diagnostics 
market is predicted to show the highest 
CAGR of 18.79% over the forecast period of 
2018-2026.
• China, India and Japan are the major 
contributors to this market. 
Request free 
sample TREY  8
research
COMPETITIVE 
INSIGHTS
Leading players in the global companion 
diagnostics market are Abbott 
Laboratories, Almac Group, Arup 
Laboratories, Biocartis, Biomerieux S.A, 
Danaher Corporation, Ge Healthcare, 
Genomic Health, Illumina Inc, Myriad 
Genetics Inc, Qiagen N.V, Roche 
Diagnostics (A Hoffmann-La Roche Ag 
Divison), Sysmex Corporation, and 
Thermo Fisher Scientific Inc.
TREY  9
research
ABOUT US
Inkwood Research specializes in syndicated research reports, 
customized research reports and consulting services. We offer market 
intelligence studies across a range of industries including Technology, 
Chemicals, Materials, Healthcare and Energy. With 20 years of 
research experience, we ensure you efficient deliverables with global 
and country industry knowledge and research expertise. Our analysis 
covers North & South America, Europe, CEE, CIS, Middle East, Africa 
and Asia.
TREY  9
research
CONTACT 
US
+1 857-302-4704
[email protected]
om
https://www.inkwoodresearch.c
om/
TREY 1
research 0
THANK YOU
Follow us on: 
TREY 
12
research 2